reference/32250036

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32250036

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	335
issn	1532-6535 0009-9236
issueIdentifier	3
pageRange	330-335
publicationName	Clinical pharmacology and therapeutics
startingPage	330
bibliographicCitation	Yu M, Xu XJ, Yin JY, Wu J, Chen X, Gong ZC, Ren HY, Huang Q, Sheng FF, Zhou HH, Liu ZQ. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes. Clin Pharmacol Ther. 2010 Mar;87(3):330–5. doi: 10.1038/clpt.2009.242. PMID: 20054294.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dd9c7ecc4c5c07eb4e27676a8c5755f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bc9b8e569fe3bf989b5b34b7c150df8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c886cef9fe4618a88e9d5c2a22b52feb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f796868d2d578e29a4bc4b2885302604 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_740a715d52858d30f56bfd3942d1b8fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_360bec26f81efe66af37b372cb7b9e3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c102cbca80eb2dcac0c3d7664ac987ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1beffca6427a0667083eb4f0b8c7d4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c043a4986b7dae8ed7219358e29261d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a9d1d186fd863f93b4e004caf5d99cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3448e3997bae598ea99667bf1f83d5d6
date	2010-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20054294 https://doi.org/10.1038/clpt.2009.242
isPartOf	https://portal.issn.org/resource/ISSN/0009-9236 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3058 https://portal.issn.org/resource/ISSN/1532-6535
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes
discusses	http://id.nlm.nih.gov/mesh/M0525648 http://id.nlm.nih.gov/mesh/M0214262 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0540929 http://id.nlm.nih.gov/mesh/M0371374 http://id.nlm.nih.gov/mesh/M0028010 http://id.nlm.nih.gov/mesh/M0481948 http://id.nlm.nih.gov/mesh/M0012835 http://id.nlm.nih.gov/mesh/M0196126 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0003327
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f66f5407985247eaf1d6f211f83bbbb0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55029e08d2afcf59a719caf55a149021 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4ba89c74214b7a1c6cb626f185c8893b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa5fc799a3f3c6277beeb3473c262800 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65981 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368393 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3767 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6934 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129583715 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127816805

Total number of triples: 60.